We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Folic Acid and Vitamin B12 for Healthy Hearts

By HospiMedica staff writers
Posted on 29 Aug 2001
A study has found that folic acid and vitamin B12 offer a cost-effective treatment for heart disease and can reduce the number of deaths due to this disease. More...
Conducted by researchers at the University of California, San Francisco (UCSF, USA), the study was published in the August 22, 2001, issue of the Journal of the American Medical Association (JAMA).

The UCSF researchers studied data on homocysteine levels. Previous studies have demonstrated that people with modestly elevated homocysteine levels have higher rates of stroke, heart attack, and death from heart disease compared to people with normal levels. Recent clinical trials have shown that folic acid can lower homocysteine levels by 25%, while the addition of vitamin B12 can decrease levels by another 7%. In 1998, the U.S. Food and Drug Administration mandated that all enriched grain products in the U.S. contain 140 micrograms of folic acid per 100 g.

The researchers used a computer model to project the effects of these supplements on the homocysteine levels of all women and men aged 35-84 if treated over a ten-year period, from 2001-2011. The results showed that heart disease rates and deaths would decrease by 8% in women and 13% in men. Among known patients with heart disease and elevated homocysteine levels, 310,000 fewer heart-disease-related deaths were projected to occur over a ten-year period if these people added a folic acid (1 mg) and vitamin B12 (0.5) supplement to their daily dose of grains enriched with folic acid.

"For most people, especially those with heart disease, taking a folic acid and vitamin B12 supplement is projected not only to be safe and save lives, but also to save money because it prevents heart disease and the costs associated with expensive medical treatments and procedures,” said Lee Goldman, M.D., senior author of the study. He added that a projected US$24 billion would be saved over the ten-year period if men and women with heart disease were treated with the supplements.




Related Links:
JAMA

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.